{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T19:44:01Z","timestamp":1792698241039,"version":"4.5.0"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T00:00:00Z","timestamp":1733443200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012476","name":"Fundamental Research Funds for Central Universities of the Central South University","doi-asserted-by":"publisher","award":["2024ZZTS0166"],"award-info":[{"award-number":["2024ZZTS0166"]}],"id":[{"id":"10.13039\/501100012476","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013069","name":"Leading Talents Program of Guangdong Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82370807"],"award-info":[{"award-number":["82370807"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81871858"],"award-info":[{"award-number":["81871858"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82172550"],"award-info":[{"award-number":["82172550"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eClinicalMedicine"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.eclinm.2024.103020","type":"journal-article","created":{"date-parts":[[2024,12,27]],"date-time":"2024-12-27T14:55:33Z","timestamp":1735311333000},"page":"103020","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":61,"special_numbering":"C","title":["Safety and effects of anti-obesity medications on weight loss, cardiometabolic, and psychological outcomes in people living\u00a0with overweight or obesity: a systematic review and meta-analysis"],"prefix":"10.1016","volume":"79","author":[{"given":"Leiling","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenrui","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pu","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yurong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luqing","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangnan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yihua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-1576-9051","authenticated-orcid":false,"given":"Runqi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2113-0800","authenticated-orcid":false,"given":"Danyan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.eclinm.2024.103020_bib1","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S2213-8587(13)70062-7","article-title":"Metabolically healthy obesity: epidemiology, mechanisms, and clinical implications","volume":"1","author":"Stefan","year":"2013","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"10.1016\/j.eclinm.2024.103020_bib2","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1001\/jama.2012.113905","article-title":"Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis","volume":"309","author":"Flegal","year":"2013","journal-title":"JAMA"},{"issue":"20","key":"10.1016\/j.eclinm.2024.103020_bib3","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1001\/jama.2023.19897","article-title":"Obesity management in adults: a review","volume":"330","author":"Elmaleh-Sachs","year":"2023","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.eclinm.2024.103020_bib4","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s40885-023-00257-2","article-title":"The association between body mass index and abdominal obesity with hypertension among South Asian population: findings from nationally representative surveys","volume":"30","author":"Gupta","year":"2024","journal-title":"Clin Hypertens"},{"issue":"6","key":"10.1016\/j.eclinm.2024.103020_bib5","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1093\/gerona\/glad051","article-title":"Association between weight status and rate of cognitive decline: China health and nutrition survey 1997-2018","volume":"78","author":"Lynch","year":"2023","journal-title":"J\u00a0Gerontol A Biol Sci Med Sci"},{"issue":"1","key":"10.1016\/j.eclinm.2024.103020_bib6","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1056\/NEJMoa1614362","article-title":"Health effects of overweight and obesity in 195 countries over 25 years","volume":"377","author":"Afshin","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"20","key":"10.1016\/j.eclinm.2024.103020_bib7","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1056\/NEJMoa0801891","article-title":"General and abdominal adiposity and risk of death in Europe","volume":"359","author":"Pischon","year":"2008","journal-title":"N\u00a0Engl J Med"},{"issue":"12","key":"10.1016\/j.eclinm.2024.103020_bib8","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1177\/2047487320908983","article-title":"Obesity, overweight and risk for cardiovascular disease and mortality in young women","volume":"28","author":"Dikaiou","year":"2021","journal-title":"Eur J Prev Cardiol"},{"issue":"10046","key":"10.1016\/j.eclinm.2024.103020_bib9","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/S0140-6736(16)30175-1","article-title":"Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents","volume":"388","author":"Global","year":"2016","journal-title":"Lancet"},{"issue":"21","key":"10.1016\/j.eclinm.2024.103020_bib10","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1016\/j.jacc.2008.12.068","article-title":"Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss","volume":"53","author":"Lavie","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"21","key":"10.1016\/j.eclinm.2024.103020_bib11","doi-asserted-by":"crossref","first-page":"e984","DOI":"10.1161\/CIR.0000000000000973","article-title":"Obesity and cardiovascular disease: a scientific statement from the American heart association","volume":"143","author":"Powell-Wiley","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.eclinm.2024.103020_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nutres.2023.10.008","article-title":"Increased body weight and central adiposity markers are positively associated with the 20-year incidence of cardiovascular disease: the ATTICA epidemiological study (2002-2022)","volume":"121","author":"Georgoulis","year":"2024","journal-title":"Nutr Res"},{"key":"10.1016\/j.eclinm.2024.103020_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijnurstu.2024.104766","article-title":"Obesity paradox of cardiovascular mortality in older adults in the United States: a cohort study using 1997-2018 National Health Interview Survey data linked with the National Death Index","volume":"155","author":"Chen","year":"2024","journal-title":"Int J Nurs Stud"},{"issue":"10382","key":"10.1016\/j.eclinm.2024.103020_bib14","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/S0140-6736(22)02403-5","article-title":"Contemporary medical, device, and surgical therapies for obesity in adults","volume":"401","author":"Perdomo","year":"2023","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.eclinm.2024.103020_bib15","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.mcna.2020.08.018","article-title":"Best practices in the management of overweight and obesity","volume":"105","author":"Tchang","year":"2021","journal-title":"Med Clin North Am"},{"issue":"5","key":"10.1016\/j.eclinm.2024.103020_bib16","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1002\/oby.22769","article-title":"Weight change 2 Years after termination of the intensive lifestyle intervention in the look AHEAD study","volume":"28","author":"Chao","year":"2020","journal-title":"Obesity"},{"issue":"Suppl 4","key":"10.1016\/j.eclinm.2024.103020_bib17","article-title":"Exercise training in the management of overweight and obesity in adults: synthesis of the evidence and recommendations from the European association for the study of obesity physical activity working group","volume":"22 Suppl 4","author":"Oppert","year":"2021","journal-title":"Obes Rev"},{"issue":"8","key":"10.1016\/j.eclinm.2024.103020_bib18","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1007\/s11695-014-1560-z","article-title":"Trends in weight regain following roux-en-Y gastric bypass (RYGB) bariatric surgery","volume":"25","author":"Cooper","year":"2015","journal-title":"Obes Surg"},{"issue":"Suppl 3","key":"10.1016\/j.eclinm.2024.103020_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4158\/EP161365.GL","article-title":"American Association of Clinical Endocrinologists and American College of Endocrinology comprehensive clinical practice guidelines for medical care of patients with obesity","volume":"22","author":"Garvey","year":"2016","journal-title":"Endocr Pract"},{"issue":"5","key":"10.1016\/j.eclinm.2024.103020_bib20","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1053\/j.gastro.2022.08.045","article-title":"AGA clinical practice guideline on pharmacological interventions for adults with obesity","volume":"163","author":"Grunvald","year":"2022","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.eclinm.2024.103020_bib21","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1002\/art.42754","article-title":"Weight loss induced by antiobesity medications and all-cause mortality among patients with knee or hip osteoarthritis","volume":"76","author":"Wei","year":"2024","journal-title":"Arthritis Rheumatol"},{"issue":"11","key":"10.1016\/j.eclinm.2024.103020_bib22","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1056\/NEJMp2003873","article-title":"Cancer risk associated with lorcaserin - the FDA's review of the CAMELLIA-TIMI 61 trial","volume":"383","author":"Sharretts","year":"2020","journal-title":"N\u00a0Engl J Med"},{"issue":"22","key":"10.1016\/j.eclinm.2024.103020_bib23","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1001\/jama.2023.24539","article-title":"FDA green-lights tirzepatide, marketed as zepbound, for chronic weight management","volume":"330","author":"Abbasi","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.eclinm.2024.103020_bib24","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"5","key":"10.1016\/j.eclinm.2024.103020_bib25","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.20f13681","article-title":"Mean difference, standardized mean difference (SMD), and their use in meta-analysis: as simple as it gets","volume":"81","author":"Andrade","year":"2020","journal-title":"J\u00a0Clin Psychiatry"},{"issue":"7","key":"10.1016\/j.eclinm.2024.103020_bib26","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1177\/21925682221110527","article-title":"Fixed-effect vs random-effects models for meta-analysis: 3 points to consider","volume":"12","author":"Dettori","year":"2022","journal-title":"Global Spine J"},{"issue":"9","key":"10.1016\/j.eclinm.2024.103020_bib27","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1007\/s00127-020-01916-7","article-title":"The prevalence of child maltreatment among Chinese primary and middle school students: a systematic review and meta-analysis","volume":"55","author":"Wang","year":"2020","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"key":"10.1016\/j.eclinm.2024.103020_bib28","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.eclinm.2024.103020_bib29","article-title":"Ultra-processed food exposure and adverse health outcomes: umbrella review of epidemiological meta-analyses","volume":"384","author":"Lane","year":"2024","journal-title":"BMJ"},{"issue":"10434","key":"10.1016\/j.eclinm.2024.103020_bib30","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/S0140-6736(24)00351-9","article-title":"Pharmacotherapy for adults with overweight and obesity: a systematic review and network meta-analysis of randomised controlled trials","volume":"403","author":"Shi","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.eclinm.2024.103020_bib31","article-title":"GRADE approach to drawing conclusions from a network meta-analysis using a minimally contextualised framework","volume":"371","author":"Brignardello-Petersen","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.eclinm.2024.103020_bib32","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.ejphar.2015.05.060","article-title":"Orlistat limits cholesterol intestinal absorption by Niemann-pick C1-like 1 (NPC1L1) inhibition","volume":"762","author":"Alqahtani","year":"2015","journal-title":"Eur J Pharmacol"},{"issue":"7","key":"10.1016\/j.eclinm.2024.103020_bib33","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1001\/jama.2024.9217","article-title":"Tirzepatide for weight reduction in Chinese adults with obesity: the SURMOUNT-CN randomized clinical trial","volume":"332","author":"Zhao","year":"2024","journal-title":"JAMA"},{"issue":"10402","key":"10.1016\/j.eclinm.2024.103020_bib34","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S0140-6736(23)01200-X","article-title":"Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial","volume":"402","author":"Garvey","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.eclinm.2024.103020_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2024.111717","article-title":"Tirzepatide 5, 10 and 15 mg versus injectable semaglutide 0.5 mg for the treatment of type 2 diabetes: an adjusted indirect treatment comparison","volume":"212","author":"Osumili","year":"2024","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.eclinm.2024.103020_bib36","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2023-076410","article-title":"Comparative effectiveness of GLP-1 receptor agonists on glycaemic control, body weight, and lipid profile for type 2 diabetes: systematic review and network meta-analysis","volume":"384","author":"Yao","year":"2024","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.eclinm.2024.103020_bib37","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s11906-019-0915-1","article-title":"Weight loss medications in the treatment of obesity and hypertension","volume":"21","author":"Cohen","year":"2019","journal-title":"Curr Hypertens Rep"},{"issue":"4","key":"10.1016\/j.eclinm.2024.103020_bib38","doi-asserted-by":"crossref","first-page":"249","DOI":"10.3109\/07853890.2010.541490","article-title":"Naltrexone sustained-release (SR)\u00a0+ bupropion SR combination therapy for the treatment of obesity: 'a new kid on the block'?","volume":"43","author":"Katsiki","year":"2011","journal-title":"Ann Med"},{"issue":"6","key":"10.1016\/j.eclinm.2024.103020_bib39","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1159\/000335352","article-title":"Naltrexone\/bupropion: an investigational combination for weight loss and maintenance","volume":"4","author":"Makowski","year":"2011","journal-title":"Obes Facts"},{"issue":"2","key":"10.1016\/j.eclinm.2024.103020_bib40","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/osp4.156","article-title":"Quality of life, binge eating and sexual function in participants treated for obesity with sustained release naltrexone\/bupropion","volume":"4","author":"Halseth","year":"2018","journal-title":"Obes Sci Pract"},{"key":"10.1016\/j.eclinm.2024.103020_bib41","doi-asserted-by":"crossref","first-page":"3049","DOI":"10.2147\/DMSO.S381652","article-title":"Use of contrave, naltrexone with bupropion, bupropion, or naltrexone and major adverse cardiovascular events: a systematic literature review","volume":"15","author":"Dahlberg","year":"2022","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"6","key":"10.1016\/j.eclinm.2024.103020_bib42","doi-asserted-by":"crossref","DOI":"10.1111\/obr.13224","article-title":"Cardiovascular safety of naltrexone and bupropion therapy: systematic review and meta-analyses","volume":"22","author":"Sposito","year":"2021","journal-title":"Obes Rev"},{"issue":"3","key":"10.1016\/j.eclinm.2024.103020_bib43","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/s41591-022-01707-4","article-title":"Tirzepatide cardiovascular event risk assessment: a pre-specified meta-analysis","volume":"28","author":"Sattar","year":"2022","journal-title":"Nat Med"},{"issue":"10313","key":"10.1016\/j.eclinm.2024.103020_bib44","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1016\/S0140-6736(21)02188-7","article-title":"Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial","volume":"398","author":"Del","year":"2021","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.eclinm.2024.103020_bib45","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1056\/NEJMoa1901118","article-title":"Oral semaglutide and cardiovascular outcomes in patients with type 2 diabetes","volume":"381","author":"Husain","year":"2019","journal-title":"N\u00a0Engl J Med"},{"issue":"19","key":"10.1016\/j.eclinm.2024.103020_bib46","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1056\/NEJMoa1607141","article-title":"Semaglutide and cardiovascular outcomes in patients with type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.eclinm.2024.103020_bib47","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.phrs.2018.09.003","article-title":"Liraglutide and cardiovascular outcomes in a real world type 2 diabetes cohort","volume":"137","author":"Mirani","year":"2018","journal-title":"Pharmacol Res"},{"issue":"4","key":"10.1016\/j.eclinm.2024.103020_bib48","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1001\/jamainternmed.2013.14629","article-title":"The new weight-loss drugs, lorcaserin and phentermine-topiramate: slim pickings?","volume":"174","author":"Woloshin","year":"2014","journal-title":"JAMA Intern Med"},{"issue":"10","key":"10.1016\/j.eclinm.2024.103020_bib49","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1176\/appi.ajp.158.10.1736","article-title":"Topiramate-induced depression","volume":"158","author":"Klufas","year":"2001","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.eclinm.2024.103020_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2024.102661","article-title":"GLP-1 receptor agonists for weight reduction in people living with obesity but without diabetes: a living benefit-harm modelling study","volume":"73","author":"Moll","year":"2024","journal-title":"eClinicalMedicine"},{"issue":"10","key":"10.1016\/j.eclinm.2024.103020_bib51","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S2213-8587(21)00203-5","article-title":"Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials","volume":"9","author":"Sattar","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"2","key":"10.1016\/j.eclinm.2024.103020_bib52","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S2213-8587(17)30412-6","article-title":"Cardiovascular outcomes with glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes: a meta-analysis","volume":"6","author":"Bethel","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"6","key":"10.1016\/j.eclinm.2024.103020_bib53","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1002\/oby.23152","article-title":"Efficacy and safety of phentermine\/topiramate in adults with overweight or obesity: a systematic review and meta-analysis","volume":"29","author":"Lei","year":"2021","journal-title":"Obesity"},{"key":"10.1016\/j.eclinm.2024.103020_bib54","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/1741-7015-11-159","article-title":"Is network meta-analysis as valid as standard pairwise meta-analysis? It all depends on the distribution of effect modifiers","volume":"11","author":"Jansen","year":"2013","journal-title":"BMC Med"}],"container-title":["eClinicalMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537024005996?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537024005996?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T20:07:20Z","timestamp":1762632440000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589537024005996"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":54,"alternative-id":["S2589537024005996"],"URL":"https:\/\/doi.org\/10.1016\/j.eclinm.2024.103020","relation":{},"ISSN":["2589-5370"],"issn-type":[{"value":"2589-5370","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety and effects of anti-obesity medications on weight loss, cardiometabolic, and psychological outcomes in people living\u00a0with overweight or obesity: a systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"eClinicalMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eclinm.2024.103020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"103020"}}